AGP Picks
View all

Massachusetts Weekly
Provided by AGP

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 8, 2026

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations
Sep. 8, 2026

Spyre Announces Potential Best-in-Class SPY003 (anti-IL-23) Part A Induction Results from SKYLINE Trial, Completing Proof-of-Concept for All Three Components of its IBD Combinations

Indeterminate GlobeNewswire
Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure
Sep. 8, 2026

Amwell Receives Letter of Intent from Department of Veterans Affairs to Help Power its Digital Health Infrastructure

Indeterminate GlobeNewswire
Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings
Sep. 8, 2026

Dyne Therapeutics to Present Additional One-Year Clinical Data from Phase 1/2 ACHIEVE Trial of Z-Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1) at Upcoming Medical Meetings

Indeterminate GlobeNewswire
CervoMed to Participate in September Investor Conferences
Sep. 8, 2026

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire
Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board
Sep. 8, 2026

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire
Generate Biomedicines Inc. to Participate in September Investor Conferences
Sep. 8, 2026

Generate Biomedicines Inc. to Participate in September Investor Conferences

Indeterminate GlobeNewswire
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
Sep. 8, 2026

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire
Robinson Unmanned R44 AIRTRUCK Demonstrates Offshore Cargo Capabilities at Acadiana Regional Airport in Louisiana
Sep. 8, 2026

Robinson Unmanned R44 AIRTRUCK Demonstrates Offshore Cargo Capabilities at Acadiana Regional Airport in Louisiana

Indeterminate GlobeNewswire
Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
Sep. 8, 2026

Atea Pharmaceuticals to Present at the Morgan Stanley 24th Annual Global Healthcare Conference

Indeterminate GlobeNewswire
Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)
Sep. 8, 2026

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Initiation of Phase 2 Clinical Study for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire
Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis
Sep. 8, 2026

Vor Completes Enrollment of Global Phase 3 UPSTREAM MG Trial and Expands Telitacicept Global Franchise into Ocular Myasthenia Gravis

Indeterminate GlobeNewswire
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Sep. 8, 2026

Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire
X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting
Sep. 8, 2026

X4 Pharmaceuticals Announces Positive Outcome from FDA Type C Meeting

Indeterminate GlobeNewswire
Global Enterprise Artificial Intelligence (AI) Market to Reach $206.6 Billion by 2031, Driven by Accelerating Cloud Infrastructure and Agentic AI Adoption
Sep. 8, 2026

Global Enterprise Artificial Intelligence (AI) Market to Reach $206.6 Billion by 2031, Driven by Accelerating Cloud Infrastructure and Agentic AI Adoption

Indeterminate GlobeNewswire
Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets
Sep. 8, 2026

Bluejay Diagnostics and Lovell Government Services Announce Partnership to Expand Access to U.S. Federal Healthcare Markets

Indeterminate GlobeNewswire
Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026
Sep. 8, 2026

Beam Therapeutics Presents Updated Clinical Data from the Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the European Respiratory Society (ERS) Congress 2026

Indeterminate GlobeNewswire
Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026
Sep. 8, 2026

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.